Skip to main
MEDP

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 9%
Hold 64%
Sell 9%
Strong Sell 18%

Bulls say

Medpace Holdings is poised for growth as it anticipates an increase of 200-300 basis points in passthrough revenues in the second half of the year compared to the already elevated levels in the second quarter. The company is benefiting from strong request-for-proposal (RFP) volume, particularly in the first quarter, which supports a positive outlook for its book-to-bill ratio, with expectations to exceed 1.15x in the third quarter. Collectively, these factors indicate robust operational performance and market demand, reinforcing a favorable financial outlook for Medpace.

Bears say

Medpace Holdings has experienced concerning trends in backlog cancellations, which remained high and were recently noted to be at the upper range of what the company considers normal, indicating potential volatility in future revenue streams. The firm's uncertainty regarding growth in Direct Service revenue further adds to apprehensions, as the company finds it premature to make definitive growth projections while expressing a mild expectation of stability through 2026. Additionally, despite a slight upward adjustment in adjusted EBITDA estimates for 2025 and 2026, the outlook is tempered by the need for continued investment in hiring and a forecasted decrease in passthrough revenues, raising questions about long-term profitability and financial sustainability.

Medpace Holdings (MEDP) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 9% advise Selling, and 18% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 11 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $479.64, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $479.64, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.